福壽園(01448.HK)採納受限制股份激勵計劃
格隆匯11月29日丨福壽園(01448.HK)公告,於2019年11月29日,公司已採納計劃以(其中包括)肯定選定參與者的貢獻。計劃將初步於採納日期起計10年期間有效及生效。根據計劃,公司可能以(i)受託人將於市場內外收購的現有股份及╱或(ii)將向受託人配發及發行的新股份應付受限制股份。
所有根據計劃授出的相關受限制股份總數合共不得超出本公司於採納日期的已發行股本總數百分三(3%)。計劃並不構成根據上市規則第十七章的購股權計劃。採納本計劃毋須獲得股東批准。公司將於計劃項下的指定期限內根據計劃規則不時作出授權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.